Last reviewed · How we verify
Benzetonium Chloride (BENZETHONIUM)
At a glance
| Generic name | BENZETHONIUM |
|---|---|
| Drug class | benzethonium |
| Target | Muscarinic acetylcholine receptor M4 |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Itching of skin
- Minor Skin Wound Pain
- Prevent Minor Bacterial Skin Infection
- Skin irritation
Common side effects
Key clinical trials
- ORCHID: An Online Intervention for Persons With HIV (Miami) (NA)
- Evaluation of the Protection of a Liquid Bandage (NA)
- Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzetonium Chloride CI brief — competitive landscape report
- Benzetonium Chloride updates RSS · CI watch RSS